KRAS and thyroid gland undifferentiated (anaplastic) carcinoma: To conclude, our results suggest K-Ras and Gal-3 as potential targets in anaplastic thyroid tumors and herald a novel treatment for highly aggressive anaplastic thyroid carcinoma.